• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996 年至 2006 年间 2 型糖尿病成人血糖控制的变化:一项纵向队列研究。

Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study.

机构信息

The Diabetes Center, Massachusetts General Hospital, 50 Staniford Street, Boston, MA 02114, USA.

出版信息

BMC Health Serv Res. 2010 Jun 9;10:158. doi: 10.1186/1472-6963-10-158.

DOI:10.1186/1472-6963-10-158
PMID:20534158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2889946/
Abstract

BACKGROUND

Our objectives were to examine temporal changes in HbA1c and lipid levels over a 10-year period and to identify predictors of metabolic control in a longitudinal patient cohort.

METHODS

We identified all adults within our hospital network with T2DM who had HbA1c's measured in both 1996 and 2006 (longitudinal cohort). For patients with no data in 2006, we used hospital and social security records to distinguish patients lost to follow-up from those who died after 1996. We compared characteristics of the 3 baseline cohorts (longitudinal, lost to f/u, died) and examined metabolic trends in the longitudinal cohort.

RESULTS

Of the 4944 patients with HbA1c measured in 1996, 1772 (36%) had an HbA1c measured in 2006, 1296 (26%) were lost to follow-up, and 1876 (38%) had died by 2006. In the longitudinal cohort, mean HbA1c decreased by 0.4 +/- 1.8% over the ten-year span (from 8.2% +/- 1.7% to 7.8% +/- 1.4%) and mean total cholesterol decreased by 49.3 (+/- 46.5) mg/dL. In a multivariate model, independent predictors of HbA1c decline included older age (OR 1.41 per decade, 95% CI: 1.3-1.6, p < 0.001), baseline HbA1c (OR 2.9 per 1% increment, 2.6 - 3.2, p < 0.001), and speaking English (OR 2.1, 1.4-3.1, p < 0.001).

CONCLUSIONS

Despite having had diabetes for an additional 10 years, patients in our longitudinal cohort had better glycemic and cholesterol control in 2006 than 1996. Greatest improvements occurred in patients with the highest levels in the baseline year.

摘要

背景

我们的目的是研究在 10 年内 HbA1c 和血脂水平的时间变化,并确定在纵向患者队列中代谢控制的预测因素。

方法

我们确定了我们医院网络中所有在 1996 年和 2006 年都有 HbA1c 测量值的 2 型糖尿病患者(纵向队列)。对于 2006 年没有数据的患者,我们使用医院和社会保障记录将失访患者与 1996 年后死亡的患者区分开来。我们比较了三个基线队列(纵向、失访、死亡)的特征,并检查了纵向队列的代谢趋势。

结果

在 4944 名 HbA1c 于 1996 年测量的患者中,1772 名(36%)在 2006 年测量了 HbA1c,1296 名(26%)失访,1876 名(38%)在 2006 年死亡。在纵向队列中,10 年内平均 HbA1c 下降 0.4±1.8%(从 8.2%±1.7%降至 7.8%±1.4%),总胆固醇平均下降 49.3(±46.5)mg/dL。在多变量模型中,HbA1c 下降的独立预测因素包括年龄较大(每 10 年增加 1.41,95%CI:1.3-1.6,p<0.001)、基线 HbA1c(每增加 1%增加 2.9,2.6-3.2,p<0.001)和讲英语(OR 2.1,1.4-3.1,p<0.001)。

结论

尽管在纵向队列中患者的糖尿病病史又增加了 10 年,但他们在 2006 年的血糖和胆固醇控制情况优于 1996 年。基线年内水平最高的患者改善最大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c10/2889946/5b8b2e6d491c/1472-6963-10-158-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c10/2889946/5f73fc7384f2/1472-6963-10-158-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c10/2889946/5b8b2e6d491c/1472-6963-10-158-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c10/2889946/5f73fc7384f2/1472-6963-10-158-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c10/2889946/5b8b2e6d491c/1472-6963-10-158-2.jpg

相似文献

1
Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study.1996 年至 2006 年间 2 型糖尿病成人血糖控制的变化:一项纵向队列研究。
BMC Health Serv Res. 2010 Jun 9;10:158. doi: 10.1186/1472-6963-10-158.
2
Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.在一项开放标签扩展研究中,格列本脲/二甲双胍片对血糖控制不佳且伴有血脂异常的2型糖尿病患者的脂质影响。
Clin Ther. 2002 Sep;24(9):1426-38. doi: 10.1016/s0149-2918(02)80046-7.
3
The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin.二甲双胍反应在新诊断2型糖尿病患者脂质代谢中的作用:以糖化血红蛋白水平作为区分二甲双胍反应者与无反应者的标准
PLoS One. 2016 Mar 15;11(3):e0151543. doi: 10.1371/journal.pone.0151543. eCollection 2016.
4
Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.在胰岛素治疗的 2 型糖尿病患者心血管风险评估研究中入组的起始胰岛素治疗的日本患者的基线和 1 年随访评估:一项国际、多中心、观察性研究。
Cardiovasc Diabetol. 2013 Sep 8;12:131. doi: 10.1186/1475-2840-12-131.
5
High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.高水平的个体血脂谱和血脂比值作为2型糖尿病血糖控制不佳的预测指标。
Vasc Health Risk Manag. 2019 Jun 5;15:149-157. doi: 10.2147/VHRM.S209830. eCollection 2019.
6
Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.厄立特里亚阿斯马拉门诊 2 型糖尿病患者血糖和血脂水平不良的相关因素:一项横断面研究。
J Diabetes Res. 2020 Jan 28;2020:5901569. doi: 10.1155/2020/5901569. eCollection 2020.
7
Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.糖尿病自我管理教育和医学营养治疗:通过回顾性图表审查记录注册营养师干预在血糖控制和糖尿病血脂异常管理中的疗效的多地点研究文件。
J Acad Nutr Diet. 2019 Mar;119(3):449-463. doi: 10.1016/j.jand.2018.06.303. Epub 2018 Sep 13.
8
Real-Life Glycemic Control in Children with Type 2 Diabetes: A Population-Based Study.2型糖尿病儿童的实际血糖控制:一项基于人群的研究。
J Pediatr. 2017 Sep;188:173-180.e1. doi: 10.1016/j.jpeds.2017.05.074. Epub 2017 Jul 8.
9
Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.卡格列净在现实世界中的应用:2型糖尿病患者的血糖控制——多数据库综合分析
Clin Ther. 2016 Sep;38(9):2071-82. doi: 10.1016/j.clinthera.2016.07.168. Epub 2016 Sep 3.
10
Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study.亚洲糖尿病患者的基线特征、血糖控制和口服抗糖尿病药物治疗评估:糖尿病管理中评估口服降糖药使用情况(REASON)亚洲研究。
J Diabetes. 2013 Sep;5(3):309-18. doi: 10.1111/1753-0407.12038. Epub 2013 May 28.

引用本文的文献

1
Stacked classifiers for individualized prediction of glycemic control following initiation of metformin therapy in type 2 diabetes.基于堆叠分类器的 2 型糖尿病患者起始二甲双胍治疗后血糖控制个体化预测
Comput Biol Med. 2018 Dec 1;103:109-115. doi: 10.1016/j.compbiomed.2018.10.017. Epub 2018 Oct 16.
2
The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).2 型糖尿病的遗留效应:早期血糖控制对未来并发症的影响(糖尿病与衰老研究)。
Diabetes Care. 2019 Mar;42(3):416-426. doi: 10.2337/dc17-1144. Epub 2018 Aug 13.
3
Trajectories of Glycemic Change in a National Cohort of Adults With Previously Controlled Type 2 Diabetes.

本文引用的文献

1
Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.未经治疗的糖化血红蛋白(A1C)低于7%的2型糖尿病患者疾病进展和开始用药的临床预测因素。
Diabetes Care. 2008 Mar;31(3):386-90. doi: 10.2337/dc07-1934. Epub 2007 Dec 14.
2
Trends in A1C concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004.1999年至2004年美国成年糖尿病确诊患者的糖化血红蛋白(A1C)浓度变化趋势。
Diabetes Care. 2008 Jan;31(1):102-4. doi: 10.2337/dc07-0565. Epub 2007 Oct 12.
3
Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004.
既往血糖控制良好的成年2型糖尿病患者全国队列中的血糖变化轨迹。
Med Care. 2017 Nov;55(11):956-964. doi: 10.1097/MLR.0000000000000807.
4
Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011.2005 - 2011年美国综合医疗服务体系中大量成年糖尿病患者发生需要医疗干预的严重低血糖情况
Diabetes Care. 2016 Mar;39(3):363-70. doi: 10.2337/dc15-0858. Epub 2015 Dec 17.
5
Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988-1991 to 2005-2008.在诊断和未诊断的糖尿病、糖尿病前期和血糖正常的成年人中,血脂和载脂蛋白 B 浓度的时间变化:1988-1991 年至 2005-2008 年全国健康和营养调查的结果。
Cardiovasc Diabetol. 2013 Jan 30;12:26. doi: 10.1186/1475-2840-12-26.
1997年至2004年糖尿病患者门诊就诊频繁且药物可负担性下降
Diabetes Care. 2006 Jun;29(6):1386-8. doi: 10.2337/dc06-0196.
4
Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.血糖变异性:一种独立于糖化血红蛋白的糖尿病并发症危险因素。
JAMA. 2006 Apr 12;295(14):1707-8. doi: 10.1001/jama.295.14.1707.
5
Factors driving diabetes care improvement in a large medical group: ten years of progress.大型医疗集团中推动糖尿病护理改善的因素:十年进展
Am J Manag Care. 2005 Aug;11(5 Suppl):S177-85.
6
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.1988年至2000年美国成年2型糖尿病患者的血糖控制情况:初步报告。
Diabetes Care. 2004 Jan;27(1):17-20. doi: 10.2337/diacare.27.1.17.
7
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.MRC/BHF糖尿病患者使用辛伐他汀降低胆固醇的心脏保护研究:一项随机安慰剂对照试验(涉及5963名糖尿病患者)
Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7.
8
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.2型糖尿病患者的多因素干预与心血管疾病
N Engl J Med. 2003 Jan 30;348(5):383-93. doi: 10.1056/NEJMoa021778.
9
The Social Security Administration's Death Master File: the completeness of death reporting at older ages.社会保障管理局的死亡主文件:老年人群死亡报告的完整性。
Soc Secur Bull. 2001;64(1):45-51.
10
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较(英国前瞻性糖尿病研究[UKPDS 33])。英国前瞻性糖尿病研究(UKPDS)小组
Lancet. 1998 Sep 12;352(9131):837-53.